MADRIGAL PHARMACEUTICALS, INC. Revenues in USD from 2012 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Madrigal Pharmaceuticals, Inc. quarterly/annual Revenues history and growth rate from 2012 to Q1 2025.
  • Madrigal Pharmaceuticals, Inc. Revenues for the quarter ending March 31, 2025 was $137M.
  • Madrigal Pharmaceuticals, Inc. annual Revenues for 2024 was $180M.
  • Madrigal Pharmaceuticals, Inc. annual Revenues for 2023 was $0.000.
  • Madrigal Pharmaceuticals, Inc. annual Revenues for 2022 was $0.000.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, Annual (USD)

MADRIGAL PHARMACEUTICALS, INC. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $137M +$137M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-01
Q1 2024 $0 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-01
Q4 2023 $0 $0 $0 Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $0 $0 $0 Jul 1, 2023 Sep 30, 2023 10-K 2024-02-28
Q2 2023 $0 $0 $0 Apr 1, 2023 Jun 30, 2023 10-K 2024-02-28
Q1 2023 $0 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $0 $0 $0 Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $0 $0 $0 Jul 1, 2022 Sep 30, 2022 10-K 2024-02-28
Q2 2022 $0 $0 $0 Apr 1, 2022 Jun 30, 2022 10-K 2024-02-28
Q1 2022 $0 $0 $0 Jan 1, 2022 Mar 31, 2022 10-K 2024-02-28
Q4 2021 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-06
Q3 2020 $0 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $0 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q3 2019 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06

MADRIGAL PHARMACEUTICALS, INC. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $180M +$180M Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2012 $147K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.